B hom

Embed Size (px)

Citation preview

  • 7/28/2019 B hom

    1/1

    IntroductionBlastocystis is a protozoan which infectshumans and some other animals.Knowledge of the life cycle is incomplete.Spread between humans is most likelyfaecal-oral.

    Some reports suggest that there is a corre-lation between the number of organismidentified in smears and the occurrence of

    symptoms, with heavy infections linked todiarrhoea and abdominal discomfort.No definition of heavy infection, however,is currently available. The problem with thishypothesis is the variable shedding of theorganisms and while in oneperiod, there may be low numbers identi-fied, a week later there may be highnumbers.

    Blastocystis hominis should be consideredto be pathogenic if the patient has persist-ent symptoms for more than three daysand it is the only organism detected inrepeat faecal specimens, or if it is the onlyorganism repeatedly identified from animmunocompromised patient.

    DiagnosisThe diagnosis is based on the identificationof the cyst-like stage in faeces. Permanentstained smears made from fixed specimensoffer greater sensitivity compared to wetmount preparations.Like all testing for parasites, the greater thenumber of collections, the greater the sen-sitivity of the testing. At least three stoolcollections are recommended, preferablyon different days. The stool specimensshould be placed immediately into SAFfixative and kept at room temperature

    until tested.

    MorphologyThe organism appears as spherical-ovalshaped cyst like structures. Size varieswidely but is usually 8-10um. Typically,there is a central body or vacuolesurrounded by a thin rim of cytoplasmcontaining up to six nuclei.

    Referenceswww.cdfound.to.it/HTML/blas.htm

    www.ksu.edu/parasitology/625tutorials/Blastocystis.html

    www.vfair.com/conditions/blastocystis.htm

    www.cdc.gov/epo/mmwr/preview/

    mmwrhtml/00016167.htm

    Sheorey, H, Walker, J, Biggs, B: ClinicalParasitology, A Handbook for MedicalPractitioners and Microbiologists,Melbourne University Press, 2000

    K Haresh et al, Trop Med Int Health1999;4:274

    Ok UZ et al, Am J Gastroenterol;94:3245

    Treatment

    Treatment should be considered in allcases, but may not be warranted inasymptomatic patients.

    Metronidazole is the first line of treatment,however resistant organisms are nowpresent in Australia and these may bedifficult to clear with treatment.Re-testing after treatment isrecommended.

    Standard dosage of Metronidazole400-750mg of Metronidazole three times a

    day for 7-10 days

    Alternative treatments include,Iodoquinol 650mg tds x 20d (Haresh et al)Trimethoprim-sulfamethoxazole (Ok UZet al) Furazolidine 8mg/kg/day (max400mgs/day) 7-10 daysCombination treatments may be required.

    Symptoms of infectionWhether or not Blastocystis causes infec-tion in humans is a point of active debate.This is because of the common occurrenceof the organism in both symptomatic andasymptomatic patients. At least 20% ofpatients in which the organism is found are

    asymptomatic. When symptomatic, theusual spectrum of symptoms includes

    Watery DiarrhoeaAbdominal PainPerianal Pruritis

    Excessive Flatulence

    Histopath is an independent NATA accredited Practice providing specialised Pathology testing

    Phone 9764 4300 Fax 9764 [email protected]

    Partners: Dr Chris Douglas, Dr Stephen Mann

    Blastocystis hominis